2024 |
Monopar Therapeutics Inc
|
Chief Executive Officer and Director |
1.1 M |
-35.7 % |
2023 |
Monopar Therapeutics Inc
|
Chief Executive Officer and Director |
1.8 M |
11.1 % |
2022 |
Monopar Therapeutics Inc
|
Chief Executive Officer and Director |
1.6 M |
23.8 % |
2021 |
Monopar Therapeutics Inc
|
Chief Executive Officer and Director |
1.4 M |
-4.1 % |
2021 |
Monopar Therapeutics Inc
|
Chief Executive Officer and Director |
1.3 M |
-13.2 % |
2020 |
Monopar Therapeutics Inc
|
Chief Executive Officer and Director |
1.6 M |
193.5 % |
2020 |
Monopar Therapeutics Inc
|
Chief Executive Officer and Director |
1.5 M |
175.3 % |
2020 |
Monopar Therapeutics Inc
|
Chief Executive Officer and Director |
1.5 M |
175.3 % |
2019 |
Monopar Therapeutics Inc
|
Chief Executive Officer and Director |
541.3 K |
-49.5 % |
2019 |
Monopar Therapeutics Inc
|
Chief Executive Officer and Director |
541.3 K |
-49.5 % |
2019 |
Monopar Therapeutics Inc
|
Chief Executive Officer and Director |
541.3 K |
-49.5 % |
2018 |
Monopar Therapeutics Inc
|
Chief Executive Officer and Director |
1.1 M |
169.2 % |
2018 |
Monopar Therapeutics Inc
|
Chief Executive Officer and Director |
1.1 M |
169.2 % |
2018 |
Monopar Therapeutics Inc
|
Chief Executive Officer and Director |
1.1 M |
167.3 % |
2017 |
Monopar Therapeutics Inc
|
- |
400.6 K |
6.8 % |
2017 |
Monopar Therapeutics Inc
|
- |
400.6 K |
6.8 % |
2016 |
Monopar Therapeutics Inc
|
- |
375.0 K |
- |